1. Home
  2. AMRX vs CRTO Comparison

AMRX vs CRTO Comparison

Compare AMRX & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • CRTO
  • Stock Information
  • Founded
  • AMRX 2002
  • CRTO 2005
  • Country
  • AMRX United States
  • CRTO France
  • Employees
  • AMRX N/A
  • CRTO N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • CRTO Advertising
  • Sector
  • AMRX Health Care
  • CRTO Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • CRTO Nasdaq
  • Market Cap
  • AMRX 2.4B
  • CRTO 2.1B
  • IPO Year
  • AMRX N/A
  • CRTO 2013
  • Fundamental
  • Price
  • AMRX $8.38
  • CRTO $35.41
  • Analyst Decision
  • AMRX Strong Buy
  • CRTO Buy
  • Analyst Count
  • AMRX 5
  • CRTO 10
  • Target Price
  • AMRX $10.80
  • CRTO $54.67
  • AVG Volume (30 Days)
  • AMRX 1.8M
  • CRTO 331.4K
  • Earning Date
  • AMRX 05-02-2025
  • CRTO 05-01-2025
  • Dividend Yield
  • AMRX N/A
  • CRTO N/A
  • EPS Growth
  • AMRX N/A
  • CRTO 115.91
  • EPS
  • AMRX N/A
  • CRTO 1.90
  • Revenue
  • AMRX $2,793,957,000.00
  • CRTO $1,933,289,000.00
  • Revenue This Year
  • AMRX $10.49
  • CRTO N/A
  • Revenue Next Year
  • AMRX $7.00
  • CRTO $7.82
  • P/E Ratio
  • AMRX N/A
  • CRTO $18.43
  • Revenue Growth
  • AMRX 16.73
  • CRTO N/A
  • 52 Week Low
  • AMRX $5.18
  • CRTO $33.15
  • 52 Week High
  • AMRX $9.48
  • CRTO $49.93
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.15
  • CRTO 40.54
  • Support Level
  • AMRX $8.18
  • CRTO $34.53
  • Resistance Level
  • AMRX $8.95
  • CRTO $38.48
  • Average True Range (ATR)
  • AMRX 0.31
  • CRTO 1.48
  • MACD
  • AMRX -0.08
  • CRTO 0.11
  • Stochastic Oscillator
  • AMRX 23.40
  • CRTO 32.53

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

Share on Social Networks: